AKT1 and breast cancer: Cannabidiol has previously been shown to deactivate Protein Kinase B/Akt (PKB) and mammalian Target of Rapamycin (mTOR) in breast cancer cells (Shrivastava et al., 2011), so we performed a dose response over 4 h to confirm this in Jurkat cells (Figure 2A).